Pompano Beach, May 2, 2013 (GLOBE NEWSWIRE) -- DS Healthcare Group Inc. (NASDAQ: DSKX), a leading developer ofpersonal care products, announced today the launch ofSpectral.DNC-N, the first product to incorporate the proprietaryNanoxidil compound, a powerful, gentle, nondrug alternative tominoxidil. The new product is formulated to help stimulate hair across theentire scalp. It employs the Nanosome-encapsulation system --proprietary to the company's DS Laboratories brand -- to transportingredients deeper into follicles for more effective results. Spectral.DNC-N is the latest addition to the Spectral line, thefirst topical treatment series to address more than 20 potentialcauses of hair thinning and loss. Spectral products target thesechallenges with multiple bioactive ingredients to promote folliclerejuvenation throughout the entire scalp, as minoxidil does at thevertex. The new formula was created to surpass the results obtained fromolder products. The innovative, nondrug biotechnology islightweight, easy to use, and does not leave a heavy, greasy, orunsightly residue, which is common with mass-market hair-growthproducts. In the hair follicle, Spectral.DNC-N generates adenosinetriphosphate, the universal currency of bioenergy, and deposits amultitude of key compounds via sophisticated delivery systems. Theformula is anti-inflammatory and antihormonal and delivershydration, nutrition, stimulation, and rejuvenation. New Nanoxidil 5%, a key compound in the product, has a lowermolecular weight and does not require the chemical solvents thatoften irritate scalp. It works well for women with noticeablethinning and for men in the early or moderate stages of thinning.It benefits users with receding hairlines or patchy eyebrows andserves as an overall preventative therapy. Uniquely lightweight and comfortable to use, Spectral.DNC-Ncontains procyanidin B-2 (apple polyphenol) to encourage hairlineas well as vertex growth, retinol for better absorption, adenosinefor cellular repair, patented Aminexil ® to counterperifollicular fibrosis, copper peptides to fight scalpinflammation, and herbal extracts to support a healthy andcomfortable overall condition. About DS Healthcare Group DS Healthcare Group Inc. leads in the development ofbiotechnology for topical, and nutritional therapies. It marketsthrough online and specialty retailers, distributors, cosmeticswholesalers, and salons. Its brands include DS Laboratories( www.DSLaboratories.com), Sigma Skin ( www.SigmaSkin.com), PolarisResearch Laboratories ( www.PolarisReserachLabs.com) and The PureGuild ( www.ThePureGuild.com). Forward-looking statements Except for statements of historical fact, the matters discussedin this press release are forward-looking and made pursuant to theSafe Harbor provisions of the Private Securities Litigation ReformAct of 1995. "Forward-looking statements" describe futureexpectations, plans, results, or strategies, and are generallypreceded by words such as "future," "plan" or "planned," "expects,"or "projected." These forward-looking statements reflect numerousassumptions and involve a variety of risks and uncertainties, manyof which are beyond the company's control that may cause actualresults to differ materially from stated expectations. These riskfactors include, among others, limited operating history,difficulty in developing and marketing products, intensecompetition, and additional risks factors as discussed in reportsfiled by the company with the Securities and Exchange Commission,which are available at http://www.sec.gov.
CONTACT: Contact: Laurel Moody Corporate Profile 1.646.810.0608